19-5211601-A-G

Variant summary

Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_002850.4(PTPRS):ā€‹c.5223T>Cā€‹(p.Ile1741=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0108 in 1,608,126 control chromosomes in the GnomAD database, including 142 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.0075 ( 9 hom., cov: 33)
Exomes š‘“: 0.011 ( 133 hom. )

Consequence

PTPRS
NM_002850.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.272
Variant links:
Genes affected
PTPRS (HGNC:9681): (protein tyrosine phosphatase receptor type S) The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains an extracellular region, a single transmembrane segment and two tandem intracytoplasmic catalytic domains, and thus represents a receptor-type PTP. The extracellular region of this protein is composed of multiple Ig-like and fibronectin type III-like domains. Studies of the similar gene in mice suggested that this PTP may be involved in cell-cell interaction, primary axonogenesis, and axon guidance during embryogenesis. This PTP has been also implicated in the molecular control of adult nerve repair. Four alternatively spliced transcript variants, which encode distinct proteins, have been reported. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant 19-5211601-A-G is Benign according to our data. Variant chr19-5211601-A-G is described in ClinVar as [Benign]. Clinvar id is 782049.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.272 with no splicing effect.
BS2
High AC in GnomAd4 at 1140 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PTPRSNM_002850.4 linkuse as main transcriptc.5223T>C p.Ile1741= synonymous_variant 33/38 ENST00000262963.11 NP_002841.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PTPRSENST00000262963.11 linkuse as main transcriptc.5223T>C p.Ile1741= synonymous_variant 33/385 NM_002850.4 ENSP00000262963 A1Q13332-1

Frequencies

GnomAD3 genomes
AF:
0.00750
AC:
1141
AN:
152200
Hom.:
9
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00212
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00229
Gnomad ASJ
AF:
0.0251
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00352
Gnomad FIN
AF:
0.0121
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0113
Gnomad OTH
AF:
0.00765
GnomAD3 exomes
AF:
0.00817
AC:
2050
AN:
250954
Hom.:
17
AF XY:
0.00849
AC XY:
1152
AN XY:
135660
show subpopulations
Gnomad AFR exome
AF:
0.00154
Gnomad AMR exome
AF:
0.00278
Gnomad ASJ exome
AF:
0.0210
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00395
Gnomad FIN exome
AF:
0.0125
Gnomad NFE exome
AF:
0.0113
Gnomad OTH exome
AF:
0.00801
GnomAD4 exome
AF:
0.0111
AC:
16211
AN:
1455808
Hom.:
133
Cov.:
33
AF XY:
0.0108
AC XY:
7832
AN XY:
722804
show subpopulations
Gnomad4 AFR exome
AF:
0.00147
Gnomad4 AMR exome
AF:
0.00280
Gnomad4 ASJ exome
AF:
0.0214
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00404
Gnomad4 FIN exome
AF:
0.0134
Gnomad4 NFE exome
AF:
0.0125
Gnomad4 OTH exome
AF:
0.00924
GnomAD4 genome
AF:
0.00748
AC:
1140
AN:
152318
Hom.:
9
Cov.:
33
AF XY:
0.00726
AC XY:
541
AN XY:
74480
show subpopulations
Gnomad4 AFR
AF:
0.00212
Gnomad4 AMR
AF:
0.00229
Gnomad4 ASJ
AF:
0.0251
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00352
Gnomad4 FIN
AF:
0.0121
Gnomad4 NFE
AF:
0.0113
Gnomad4 OTH
AF:
0.00710
Alfa
AF:
0.0107
Hom.:
3
Bravo
AF:
0.00644
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.0104
EpiControl
AF:
0.0104

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenDec 01, 2022PTPRS: BP4, BP7, BS1, BS2 -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 31, 2019- -
PTPRS-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesJun 07, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.61
CADD
Benign
4.0
DANN
Benign
0.61
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs41276864; hg19: chr19-5211612; COSMIC: COSV99508547; COSMIC: COSV99508547; API